nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—Everolimus—kidney cancer	0.164	0.293	CbGbCtD
Avanafil—CYP3A4—Temsirolimus—kidney cancer	0.111	0.198	CbGbCtD
Avanafil—CYP3A4—Pazopanib—kidney cancer	0.0583	0.104	CbGbCtD
Avanafil—CYP3A4—Erlotinib—kidney cancer	0.0416	0.0741	CbGbCtD
Avanafil—CYP3A4—Paclitaxel—kidney cancer	0.0381	0.0678	CbGbCtD
Avanafil—CYP3A4—Sorafenib—kidney cancer	0.0338	0.0603	CbGbCtD
Avanafil—CYP3A4—Vinblastine—kidney cancer	0.0334	0.0595	CbGbCtD
Avanafil—CYP3A4—Vincristine—kidney cancer	0.0328	0.0585	CbGbCtD
Avanafil—CYP3A4—Sunitinib—kidney cancer	0.0274	0.0488	CbGbCtD
Avanafil—CYP3A4—Doxorubicin—kidney cancer	0.0205	0.0366	CbGbCtD
Avanafil—PDE5A—cGMP effects—KCNMA1—kidney cancer	0.00125	0.228	CbGpPWpGaD
Avanafil—PDE5A—Nitric oxide stimulates guanylate cyclase—KCNMA1—kidney cancer	0.000991	0.181	CbGpPWpGaD
Avanafil—PDE5A—Platelet homeostasis—KCNMA1—kidney cancer	0.000386	0.0705	CbGpPWpGaD
Avanafil—Asthenia—Everolimus—kidney cancer	0.000384	0.000887	CcSEcCtD
Avanafil—Cough—Gemcitabine—kidney cancer	0.000384	0.000886	CcSEcCtD
Avanafil—Angiopathy—Paclitaxel—kidney cancer	0.000384	0.000886	CcSEcCtD
Avanafil—Constipation—Sunitinib—kidney cancer	0.000383	0.000883	CcSEcCtD
Avanafil—Immune system disorder—Paclitaxel—kidney cancer	0.000382	0.000882	CcSEcCtD
Avanafil—Mediastinal disorder—Paclitaxel—kidney cancer	0.000381	0.00088	CcSEcCtD
Avanafil—Hypertension—Gemcitabine—kidney cancer	0.00038	0.000876	CcSEcCtD
Avanafil—Pruritus—Everolimus—kidney cancer	0.000379	0.000875	CcSEcCtD
Avanafil—Infection—Vincristine—kidney cancer	0.000376	0.000868	CcSEcCtD
Avanafil—Urinary tract infection—Capecitabine—kidney cancer	0.000376	0.000868	CcSEcCtD
Avanafil—Arthralgia—Gemcitabine—kidney cancer	0.000374	0.000864	CcSEcCtD
Avanafil—Myalgia—Gemcitabine—kidney cancer	0.000374	0.000864	CcSEcCtD
Avanafil—Chest pain—Gemcitabine—kidney cancer	0.000374	0.000864	CcSEcCtD
Avanafil—Diabetes mellitus—Doxorubicin—kidney cancer	0.000372	0.000858	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000372	0.000858	CcSEcCtD
Avanafil—Nervous system disorder—Vincristine—kidney cancer	0.000371	0.000856	CcSEcCtD
Avanafil—Asthenia—Erlotinib—kidney cancer	0.000371	0.000856	CcSEcCtD
Avanafil—Mental disorder—Paclitaxel—kidney cancer	0.000371	0.000855	CcSEcCtD
Avanafil—Haematuria—Capecitabine—kidney cancer	0.000369	0.000851	CcSEcCtD
Avanafil—Malnutrition—Paclitaxel—kidney cancer	0.000368	0.00085	CcSEcCtD
Avanafil—Diarrhoea—Vinblastine—kidney cancer	0.000368	0.000849	CcSEcCtD
Avanafil—Body temperature increased—Sorafenib—kidney cancer	0.000368	0.000848	CcSEcCtD
Avanafil—Diarrhoea—Everolimus—kidney cancer	0.000366	0.000846	CcSEcCtD
Avanafil—Pruritus—Erlotinib—kidney cancer	0.000366	0.000844	CcSEcCtD
Avanafil—Fatigue—Dactinomycin—kidney cancer	0.000365	0.000843	CcSEcCtD
Avanafil—Epistaxis—Capecitabine—kidney cancer	0.000365	0.000842	CcSEcCtD
Avanafil—Infection—Gemcitabine—kidney cancer	0.000357	0.000823	CcSEcCtD
Avanafil—Back pain—Paclitaxel—kidney cancer	0.000356	0.000822	CcSEcCtD
Avanafil—Dizziness—Vinblastine—kidney cancer	0.000356	0.000821	CcSEcCtD
Avanafil—Dizziness—Everolimus—kidney cancer	0.000354	0.000817	CcSEcCtD
Avanafil—Muscle spasms—Paclitaxel—kidney cancer	0.000354	0.000817	CcSEcCtD
Avanafil—Body temperature increased—Sunitinib—kidney cancer	0.000354	0.000816	CcSEcCtD
Avanafil—Diarrhoea—Erlotinib—kidney cancer	0.000354	0.000816	CcSEcCtD
Avanafil—Hypotension—Vincristine—kidney cancer	0.000354	0.000816	CcSEcCtD
Avanafil—Nervous system disorder—Gemcitabine—kidney cancer	0.000352	0.000813	CcSEcCtD
Avanafil—Skin disorder—Gemcitabine—kidney cancer	0.000349	0.000805	CcSEcCtD
Avanafil—Vision blurred—Paclitaxel—kidney cancer	0.000347	0.000801	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—kidney cancer	0.000346	0.000798	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000345	0.000796	CcSEcCtD
Avanafil—Urinary tract disorder—Capecitabine—kidney cancer	0.000343	0.000791	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—kidney cancer	0.000343	0.000791	CcSEcCtD
Avanafil—Insomnia—Vincristine—kidney cancer	0.000342	0.00079	CcSEcCtD
Avanafil—Oedema peripheral—Capecitabine—kidney cancer	0.000342	0.000789	CcSEcCtD
Avanafil—Vomiting—Vinblastine—kidney cancer	0.000342	0.000789	CcSEcCtD
Avanafil—Dizziness—Erlotinib—kidney cancer	0.000342	0.000789	CcSEcCtD
Avanafil—Connective tissue disorder—Capecitabine—kidney cancer	0.000341	0.000787	CcSEcCtD
Avanafil—Vomiting—Everolimus—kidney cancer	0.000341	0.000786	CcSEcCtD
Avanafil—Urethral disorder—Capecitabine—kidney cancer	0.00034	0.000785	CcSEcCtD
Avanafil—Agitation—Paclitaxel—kidney cancer	0.000338	0.000781	CcSEcCtD
Avanafil—Rash—Everolimus—kidney cancer	0.000338	0.000779	CcSEcCtD
Avanafil—Dermatitis—Everolimus—kidney cancer	0.000337	0.000779	CcSEcCtD
Avanafil—Headache—Vinblastine—kidney cancer	0.000337	0.000777	CcSEcCtD
Avanafil—Headache—Everolimus—kidney cancer	0.000336	0.000774	CcSEcCtD
Avanafil—Hypotension—Gemcitabine—kidney cancer	0.000335	0.000774	CcSEcCtD
Avanafil—Body temperature increased—Dactinomycin—kidney cancer	0.000335	0.000773	CcSEcCtD
Avanafil—Asthenia—Sorafenib—kidney cancer	0.000334	0.00077	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—kidney cancer	0.000331	0.000765	CcSEcCtD
Avanafil—Vertigo—Paclitaxel—kidney cancer	0.000331	0.000764	CcSEcCtD
Avanafil—Pruritus—Sorafenib—kidney cancer	0.000329	0.000759	CcSEcCtD
Avanafil—Vomiting—Erlotinib—kidney cancer	0.000329	0.000758	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000327	0.000755	CcSEcCtD
Avanafil—Gastrointestinal disorder—Vincristine—kidney cancer	0.000327	0.000754	CcSEcCtD
Avanafil—Fatigue—Vincristine—kidney cancer	0.000326	0.000753	CcSEcCtD
Avanafil—Rash—Erlotinib—kidney cancer	0.000326	0.000752	CcSEcCtD
Avanafil—Dermatitis—Erlotinib—kidney cancer	0.000326	0.000751	CcSEcCtD
Avanafil—Palpitations—Paclitaxel—kidney cancer	0.000325	0.000751	CcSEcCtD
Avanafil—Insomnia—Gemcitabine—kidney cancer	0.000325	0.000749	CcSEcCtD
Avanafil—Eye disorder—Capecitabine—kidney cancer	0.000324	0.000749	CcSEcCtD
Avanafil—Headache—Erlotinib—kidney cancer	0.000324	0.000747	CcSEcCtD
Avanafil—Constipation—Vincristine—kidney cancer	0.000324	0.000747	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—kidney cancer	0.000323	0.000747	CcSEcCtD
Avanafil—Cardiac disorder—Capecitabine—kidney cancer	0.000322	0.000744	CcSEcCtD
Avanafil—Flushing—Capecitabine—kidney cancer	0.000322	0.000744	CcSEcCtD
Avanafil—Cough—Paclitaxel—kidney cancer	0.000321	0.000742	CcSEcCtD
Avanafil—Asthenia—Sunitinib—kidney cancer	0.000321	0.000741	CcSEcCtD
Avanafil—Nausea—Vinblastine—kidney cancer	0.000319	0.000737	CcSEcCtD
Avanafil—Somnolence—Gemcitabine—kidney cancer	0.000319	0.000737	CcSEcCtD
Avanafil—Nausea—Everolimus—kidney cancer	0.000318	0.000734	CcSEcCtD
Avanafil—Diarrhoea—Sorafenib—kidney cancer	0.000318	0.000734	CcSEcCtD
Avanafil—Hypertension—Paclitaxel—kidney cancer	0.000318	0.000734	CcSEcCtD
Avanafil—Pruritus—Sunitinib—kidney cancer	0.000317	0.000731	CcSEcCtD
Avanafil—Angiopathy—Capecitabine—kidney cancer	0.000315	0.000727	CcSEcCtD
Avanafil—Immune system disorder—Capecitabine—kidney cancer	0.000314	0.000724	CcSEcCtD
Avanafil—Chest pain—Paclitaxel—kidney cancer	0.000314	0.000724	CcSEcCtD
Avanafil—Myalgia—Paclitaxel—kidney cancer	0.000314	0.000724	CcSEcCtD
Avanafil—Arthralgia—Paclitaxel—kidney cancer	0.000314	0.000724	CcSEcCtD
Avanafil—PDE5A—Platelet homeostasis—ITPR2—kidney cancer	0.000313	0.0572	CbGpPWpGaD
Avanafil—Mediastinal disorder—Capecitabine—kidney cancer	0.000313	0.000722	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000311	0.000719	CcSEcCtD
Avanafil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00031	0.000715	CcSEcCtD
Avanafil—Fatigue—Gemcitabine—kidney cancer	0.000309	0.000714	CcSEcCtD
Avanafil—Dizziness—Sorafenib—kidney cancer	0.000307	0.00071	CcSEcCtD
Avanafil—Constipation—Gemcitabine—kidney cancer	0.000307	0.000709	CcSEcCtD
Avanafil—Nausea—Erlotinib—kidney cancer	0.000307	0.000709	CcSEcCtD
Avanafil—Dry mouth—Paclitaxel—kidney cancer	0.000307	0.000708	CcSEcCtD
Avanafil—Diarrhoea—Sunitinib—kidney cancer	0.000306	0.000706	CcSEcCtD
Avanafil—Mental disorder—Capecitabine—kidney cancer	0.000304	0.000702	CcSEcCtD
Avanafil—Asthenia—Dactinomycin—kidney cancer	0.000304	0.000701	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—kidney cancer	0.000303	0.000699	CcSEcCtD
Avanafil—Malnutrition—Capecitabine—kidney cancer	0.000302	0.000698	CcSEcCtD
Avanafil—Body temperature increased—Vincristine—kidney cancer	0.000299	0.00069	CcSEcCtD
Avanafil—Infection—Paclitaxel—kidney cancer	0.000299	0.000689	CcSEcCtD
Avanafil—Dizziness—Sunitinib—kidney cancer	0.000296	0.000683	CcSEcCtD
Avanafil—Vomiting—Sorafenib—kidney cancer	0.000296	0.000682	CcSEcCtD
Avanafil—Nervous system disorder—Paclitaxel—kidney cancer	0.000295	0.00068	CcSEcCtD
Avanafil—Tachycardia—Paclitaxel—kidney cancer	0.000293	0.000677	CcSEcCtD
Avanafil—Rash—Sorafenib—kidney cancer	0.000293	0.000677	CcSEcCtD
Avanafil—Dermatitis—Sorafenib—kidney cancer	0.000293	0.000676	CcSEcCtD
Avanafil—Back pain—Capecitabine—kidney cancer	0.000292	0.000675	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—kidney cancer	0.000292	0.000675	CcSEcCtD
Avanafil—Skin disorder—Paclitaxel—kidney cancer	0.000292	0.000674	CcSEcCtD
Avanafil—Headache—Sorafenib—kidney cancer	0.000291	0.000672	CcSEcCtD
Avanafil—Muscle spasms—Capecitabine—kidney cancer	0.000291	0.000671	CcSEcCtD
Avanafil—Diarrhoea—Dactinomycin—kidney cancer	0.00029	0.000669	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—kidney cancer	0.000289	0.000668	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—kidney cancer	0.000286	0.000661	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000285	0.000658	CcSEcCtD
Avanafil—Vision blurred—Capecitabine—kidney cancer	0.000285	0.000657	CcSEcCtD
Avanafil—Vomiting—Sunitinib—kidney cancer	0.000284	0.000657	CcSEcCtD
Avanafil—Body temperature increased—Gemcitabine—kidney cancer	0.000284	0.000655	CcSEcCtD
Avanafil—Rash—Sunitinib—kidney cancer	0.000282	0.000651	CcSEcCtD
Avanafil—Dermatitis—Sunitinib—kidney cancer	0.000282	0.00065	CcSEcCtD
Avanafil—Hypotension—Paclitaxel—kidney cancer	0.000281	0.000648	CcSEcCtD
Avanafil—Headache—Sunitinib—kidney cancer	0.00028	0.000647	CcSEcCtD
Avanafil—Influenza—Doxorubicin—kidney cancer	0.00028	0.000645	CcSEcCtD
Avanafil—Nausea—Sorafenib—kidney cancer	0.000276	0.000637	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000274	0.000632	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—kidney cancer	0.000272	0.000629	CcSEcCtD
Avanafil—Insomnia—Paclitaxel—kidney cancer	0.000272	0.000627	CcSEcCtD
Avanafil—Vertigo—Capecitabine—kidney cancer	0.000272	0.000627	CcSEcCtD
Avanafil—Asthenia—Vincristine—kidney cancer	0.000271	0.000627	CcSEcCtD
Avanafil—Vomiting—Dactinomycin—kidney cancer	0.000269	0.000622	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—kidney cancer	0.000269	0.000621	CcSEcCtD
Avanafil—Somnolence—Paclitaxel—kidney cancer	0.000267	0.000617	CcSEcCtD
Avanafil—Palpitations—Capecitabine—kidney cancer	0.000267	0.000616	CcSEcCtD
Avanafil—Rash—Dactinomycin—kidney cancer	0.000267	0.000616	CcSEcCtD
Avanafil—Nausea—Sunitinib—kidney cancer	0.000266	0.000613	CcSEcCtD
Avanafil—Dyspepsia—Paclitaxel—kidney cancer	0.000265	0.000611	CcSEcCtD
Avanafil—Cough—Capecitabine—kidney cancer	0.000264	0.000609	CcSEcCtD
Avanafil—Hypertension—Capecitabine—kidney cancer	0.000261	0.000602	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.00026	0.0006	CcSEcCtD
Avanafil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000259	0.000599	CcSEcCtD
Avanafil—Fatigue—Paclitaxel—kidney cancer	0.000259	0.000598	CcSEcCtD
Avanafil—Diarrhoea—Vincristine—kidney cancer	0.000259	0.000598	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—kidney cancer	0.000258	0.000596	CcSEcCtD
Avanafil—Asthenia—Gemcitabine—kidney cancer	0.000258	0.000594	CcSEcCtD
Avanafil—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000257	0.047	CbGpPWpGaD
Avanafil—Myalgia—Capecitabine—kidney cancer	0.000257	0.000594	CcSEcCtD
Avanafil—Chest pain—Capecitabine—kidney cancer	0.000257	0.000594	CcSEcCtD
Avanafil—Arthralgia—Capecitabine—kidney cancer	0.000257	0.000594	CcSEcCtD
Avanafil—Constipation—Paclitaxel—kidney cancer	0.000257	0.000593	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000256	0.00059	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—kidney cancer	0.000254	0.000587	CcSEcCtD
Avanafil—Pruritus—Gemcitabine—kidney cancer	0.000254	0.000586	CcSEcCtD
Avanafil—Dry mouth—Capecitabine—kidney cancer	0.000252	0.000581	CcSEcCtD
Avanafil—Nausea—Dactinomycin—kidney cancer	0.000252	0.000581	CcSEcCtD
Avanafil—Dizziness—Vincristine—kidney cancer	0.00025	0.000578	CcSEcCtD
Avanafil—Infestation—Doxorubicin—kidney cancer	0.000249	0.000575	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—kidney cancer	0.000249	0.000575	CcSEcCtD
Avanafil—Diarrhoea—Gemcitabine—kidney cancer	0.000246	0.000567	CcSEcCtD
Avanafil—Infection—Capecitabine—kidney cancer	0.000245	0.000566	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—kidney cancer	0.000242	0.000559	CcSEcCtD
Avanafil—Nervous system disorder—Capecitabine—kidney cancer	0.000242	0.000558	CcSEcCtD
Avanafil—Tachycardia—Capecitabine—kidney cancer	0.000241	0.000556	CcSEcCtD
Avanafil—Vomiting—Vincristine—kidney cancer	0.000241	0.000555	CcSEcCtD
Avanafil—Skin disorder—Capecitabine—kidney cancer	0.00024	0.000553	CcSEcCtD
Avanafil—Rash—Vincristine—kidney cancer	0.000239	0.000551	CcSEcCtD
Avanafil—Dermatitis—Vincristine—kidney cancer	0.000238	0.00055	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—kidney cancer	0.000238	0.000549	CcSEcCtD
Avanafil—Body temperature increased—Paclitaxel—kidney cancer	0.000238	0.000548	CcSEcCtD
Avanafil—Headache—Vincristine—kidney cancer	0.000237	0.000547	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—kidney cancer	0.000235	0.000543	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—kidney cancer	0.000234	0.00054	CcSEcCtD
Avanafil—Hypotension—Capecitabine—kidney cancer	0.00023	0.000532	CcSEcCtD
Avanafil—Vomiting—Gemcitabine—kidney cancer	0.000228	0.000527	CcSEcCtD
Avanafil—Rash—Gemcitabine—kidney cancer	0.000226	0.000522	CcSEcCtD
Avanafil—Dermatitis—Gemcitabine—kidney cancer	0.000226	0.000522	CcSEcCtD
Avanafil—Headache—Gemcitabine—kidney cancer	0.000225	0.000519	CcSEcCtD
Avanafil—Nausea—Vincristine—kidney cancer	0.000225	0.000519	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000225	0.000519	CcSEcCtD
Avanafil—Insomnia—Capecitabine—kidney cancer	0.000223	0.000515	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—kidney cancer	0.000221	0.00051	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—kidney cancer	0.00022	0.000509	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—kidney cancer	0.00022	0.000508	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—kidney cancer	0.000219	0.000506	CcSEcCtD
Avanafil—Dyspepsia—Capecitabine—kidney cancer	0.000217	0.000501	CcSEcCtD
Avanafil—Asthenia—Paclitaxel—kidney cancer	0.000216	0.000498	CcSEcCtD
Avanafil—Nausea—Gemcitabine—kidney cancer	0.000213	0.000492	CcSEcCtD
Avanafil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000213	0.000491	CcSEcCtD
Avanafil—Fatigue—Capecitabine—kidney cancer	0.000213	0.000491	CcSEcCtD
Avanafil—Pruritus—Paclitaxel—kidney cancer	0.000213	0.000491	CcSEcCtD
Avanafil—Constipation—Capecitabine—kidney cancer	0.000211	0.000487	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—kidney cancer	0.000209	0.000483	CcSEcCtD
Avanafil—Flushing—Doxorubicin—kidney cancer	0.000208	0.000479	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—kidney cancer	0.000208	0.000479	CcSEcCtD
Avanafil—Diarrhoea—Paclitaxel—kidney cancer	0.000206	0.000475	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—kidney cancer	0.000203	0.000469	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—kidney cancer	0.000202	0.000467	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—kidney cancer	0.000202	0.000465	CcSEcCtD
Avanafil—Dizziness—Paclitaxel—kidney cancer	0.000199	0.000459	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—kidney cancer	0.000196	0.000452	CcSEcCtD
Avanafil—Body temperature increased—Capecitabine—kidney cancer	0.000195	0.00045	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—kidney cancer	0.000195	0.00045	CcSEcCtD
Avanafil—Vomiting—Paclitaxel—kidney cancer	0.000191	0.000441	CcSEcCtD
Avanafil—Rash—Paclitaxel—kidney cancer	0.00019	0.000437	CcSEcCtD
Avanafil—Dermatitis—Paclitaxel—kidney cancer	0.000189	0.000437	CcSEcCtD
Avanafil—Back pain—Doxorubicin—kidney cancer	0.000188	0.000435	CcSEcCtD
Avanafil—Headache—Paclitaxel—kidney cancer	0.000188	0.000435	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—kidney cancer	0.000187	0.000432	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—kidney cancer	0.000184	0.000424	CcSEcCtD
Avanafil—Agitation—Doxorubicin—kidney cancer	0.000179	0.000413	CcSEcCtD
Avanafil—Nausea—Paclitaxel—kidney cancer	0.000179	0.000412	CcSEcCtD
Avanafil—Asthenia—Capecitabine—kidney cancer	0.000177	0.000408	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—kidney cancer	0.000175	0.000404	CcSEcCtD
Avanafil—Pruritus—Capecitabine—kidney cancer	0.000175	0.000403	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—kidney cancer	0.000172	0.000397	CcSEcCtD
Avanafil—Cough—Doxorubicin—kidney cancer	0.00017	0.000392	CcSEcCtD
Avanafil—Diarrhoea—Capecitabine—kidney cancer	0.000169	0.000389	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—kidney cancer	0.000168	0.000388	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—kidney cancer	0.000166	0.000383	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—kidney cancer	0.000166	0.000383	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—kidney cancer	0.000166	0.000383	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000165	0.00038	CcSEcCtD
Avanafil—Dizziness—Capecitabine—kidney cancer	0.000163	0.000376	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—kidney cancer	0.000162	0.000374	CcSEcCtD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000162	0.0296	CbGpPWpGaD
Avanafil—Infection—Doxorubicin—kidney cancer	0.000158	0.000365	CcSEcCtD
Avanafil—Vomiting—Capecitabine—kidney cancer	0.000157	0.000362	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—kidney cancer	0.000156	0.00036	CcSEcCtD
Avanafil—Rash—Capecitabine—kidney cancer	0.000156	0.000359	CcSEcCtD
Avanafil—Dermatitis—Capecitabine—kidney cancer	0.000155	0.000359	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—kidney cancer	0.000155	0.000358	CcSEcCtD
Avanafil—Headache—Capecitabine—kidney cancer	0.000155	0.000357	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—kidney cancer	0.000154	0.000356	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—kidney cancer	0.000149	0.000343	CcSEcCtD
Avanafil—Nausea—Capecitabine—kidney cancer	0.000147	0.000338	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000145	0.000334	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—kidney cancer	0.000144	0.000332	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—kidney cancer	0.000141	0.000326	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—kidney cancer	0.00014	0.000323	CcSEcCtD
Avanafil—PDE5A—Hemostasis—L1CAM—kidney cancer	0.000138	0.0251	CbGpPWpGaD
Avanafil—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000137	0.000317	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—kidney cancer	0.000137	0.000316	CcSEcCtD
Avanafil—Constipation—Doxorubicin—kidney cancer	0.000136	0.000314	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—kidney cancer	0.000126	0.00029	CcSEcCtD
Avanafil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000117	0.0214	CbGpPWpGaD
Avanafil—Asthenia—Doxorubicin—kidney cancer	0.000114	0.000263	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—kidney cancer	0.000112	0.00026	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—kidney cancer	0.000109	0.000251	CcSEcCtD
Avanafil—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000109	0.0198	CbGpPWpGaD
Avanafil—Dizziness—Doxorubicin—kidney cancer	0.000105	0.000243	CcSEcCtD
Avanafil—PDE5A—Hemostasis—ANXA2—kidney cancer	0.000104	0.0191	CbGpPWpGaD
Avanafil—Vomiting—Doxorubicin—kidney cancer	0.000101	0.000233	CcSEcCtD
Avanafil—Rash—Doxorubicin—kidney cancer	0.0001	0.000231	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—kidney cancer	0.0001	0.000231	CcSEcCtD
Avanafil—Headache—Doxorubicin—kidney cancer	9.96e-05	0.00023	CcSEcCtD
Avanafil—Nausea—Doxorubicin—kidney cancer	9.44e-05	0.000218	CcSEcCtD
Avanafil—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	9.22e-05	0.0168	CbGpPWpGaD
Avanafil—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	9.1e-05	0.0166	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—KCNMA1—kidney cancer	8.65e-05	0.0158	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—GRB7—kidney cancer	7.54e-05	0.0138	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—ITPR2—kidney cancer	7.01e-05	0.0128	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	6.95e-05	0.0127	CbGpPWpGaD
Avanafil—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	5.95e-05	0.0109	CbGpPWpGaD
Avanafil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	5.74e-05	0.0105	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	5.51e-05	0.0101	CbGpPWpGaD
Avanafil—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	5.23e-05	0.00955	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IFNA1—kidney cancer	5.15e-05	0.0094	CbGpPWpGaD
Avanafil—CYP3A4—Irinotecan Pathway—APC—kidney cancer	5.01e-05	0.00914	CbGpPWpGaD
Avanafil—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	4.8e-05	0.00877	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IFNA2—kidney cancer	4.79e-05	0.00875	CbGpPWpGaD
Avanafil—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	4.62e-05	0.00844	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	4.56e-05	0.00832	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ACY1—kidney cancer	4.42e-05	0.00807	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IGF2—kidney cancer	4.31e-05	0.00788	CbGpPWpGaD
Avanafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	3.58e-05	0.00655	CbGpPWpGaD
Avanafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	3.41e-05	0.00624	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.51e-05	0.00458	CbGpPWpGaD
Avanafil—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	2.47e-05	0.00451	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	2.42e-05	0.00442	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—RAF1—kidney cancer	2.37e-05	0.00434	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—IL2—kidney cancer	2.13e-05	0.00389	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.99e-05	0.00364	CbGpPWpGaD
Avanafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.97e-05	0.0036	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—VEGFA—kidney cancer	1.81e-05	0.0033	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—MAPK3—kidney cancer	1.71e-05	0.00313	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—MAPK1—kidney cancer	1.63e-05	0.00297	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.62e-05	0.00295	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—KRAS—kidney cancer	1.54e-05	0.00281	CbGpPWpGaD
Avanafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.49e-05	0.00272	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.42e-05	0.0026	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—PIK3CA—kidney cancer	1.41e-05	0.00258	CbGpPWpGaD
Avanafil—PDE5A—Hemostasis—TP53—kidney cancer	1.37e-05	0.0025	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.33e-05	0.00243	CbGpPWpGaD
Avanafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.21e-05	0.0022	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTP1—kidney cancer	9.86e-06	0.0018	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	9.73e-06	0.00178	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—GSTM1—kidney cancer	9.06e-06	0.00165	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	8.94e-06	0.00163	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	8.59e-06	0.00157	CbGpPWpGaD
Avanafil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	8.47e-06	0.00155	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACY1—kidney cancer	7.56e-06	0.00138	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PDHB—kidney cancer	6.43e-06	0.00117	CbGpPWpGaD
Avanafil—CYP3A4—Biological oxidations—POMC—kidney cancer	6.41e-06	0.00117	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CCBL1—kidney cancer	6.04e-06	0.0011	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.24e-06	0.000957	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PPAT—kidney cancer	5.24e-06	0.000957	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—APRT—kidney cancer	4.87e-06	0.000889	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—FH—kidney cancer	4.87e-06	0.000889	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GPC3—kidney cancer	4.58e-06	0.000836	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CA2—kidney cancer	4.45e-06	0.000813	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALAD—kidney cancer	4.34e-06	0.000793	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.24e-06	0.000774	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.14e-06	0.000756	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.97e-06	0.000725	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PGK1—kidney cancer	3.97e-06	0.000725	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—LDHB—kidney cancer	3.89e-06	0.000711	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CA9—kidney cancer	3.38e-06	0.000616	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CRABP1—kidney cancer	2.87e-06	0.000524	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ITPR2—kidney cancer	2.67e-06	0.000487	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ACHE—kidney cancer	2.43e-06	0.000444	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTT1—kidney cancer	2.43e-06	0.000444	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SCARB1—kidney cancer	2.3e-06	0.000421	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGS1—kidney cancer	2.28e-06	0.000416	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PSMD7—kidney cancer	2.24e-06	0.000408	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—BCHE—kidney cancer	2.12e-06	0.000387	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.09e-06	0.000382	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.02e-06	0.000369	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTP1—kidney cancer	1.69e-06	0.000308	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—ABCB1—kidney cancer	1.6e-06	0.000292	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—GSTM1—kidney cancer	1.55e-06	0.000283	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.47e-06	0.000268	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—POMC—kidney cancer	1.1e-06	0.0002	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTGS2—kidney cancer	8.74e-07	0.00016	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PTEN—kidney cancer	7.62e-07	0.000139	CbGpPWpGaD
Avanafil—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.38e-07	9.82e-05	CbGpPWpGaD
